Skip to main content
Log in

QOL assessment is clinically relevant in patients with rheumatoid arthritis

  • Drug Economics and Quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bell MJ, et al. Arth Rheum 33: 591–601, 1990

    Article  CAS  Google Scholar 

  2. Bendtsen P, et al. PharmacoEconomics 5: 286–298, 1994

    Article  PubMed  CAS  Google Scholar 

  3. Bendtsen P, Hörnquist JO. Qual Life Res 1: 297–305, 1992

    Article  Google Scholar 

  4. Jaeschke R, et al. PharmacoEconomics 1: 84–94, 1992

    Article  PubMed  CAS  Google Scholar 

  5. Bendtsen P, Hörnquist JO. Clin Exp Rheumatol 11: 495–502, 1993

    PubMed  CAS  Google Scholar 

  6. Makisara GL, Makisara P. Clin Rheumatol 1: 117–125, 1982

    Article  PubMed  CAS  Google Scholar 

  7. Wolfe F. J Rheumatol 17 (Suppl. 22): 24–32, 1990

    Google Scholar 

  8. Borstlap M, et al. Clin Rheum 13: 45–50, 1994

    Article  CAS  Google Scholar 

  9. Tugwell P, et al. Arch Intern Med 150: 59–62, 1990

    Article  PubMed  CAS  Google Scholar 

  10. Borg G, et al. J Rheumatol 18: 1015–1020, 1991

    PubMed  CAS  Google Scholar 

  11. Bombardier C, et al. Am J Med 81: 565–578, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

QOL assessment is clinically relevant in patients with rheumatoid arthritis. Drugs Ther. Perspect 4, 14–16 (1994). https://doi.org/10.2165/00042310-199404060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199404060-00007

Keywords

Navigation